<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211223053495N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-06-10</date_registration>
      <primary_sponsor>Razi University</primary_sponsor>
      <public_title>Biomarkers and Acute Mountain Sickness after Active and Passive Ascents to High Altitude</public_title>
      <acronym></acronym>
      <scientific_title>Biomarkers and Acute Mountain Sickness after Active and Passive Ascents to High Altitude in Healthy Men</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>15</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61286</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Crossover, Purpose: Prevention, Randomization description: Permuted block randomization: Allocation of subjects will be performed using permuted block randomization with two blocks of eight (one block for the mountaineering and one block for the cable car group). To do this, random allocation software will be used, and someone other than the researchers involved in performing the interventions and measurements will perform it. The random allocation software is a free software that can support block randomization (Version 1.0, May 2004; downloadable at https://mahmoodsaghaei.tripod.com/Softwares/randalloc.html). Each participant will be given a unique code (e.g. 01, 02, 03 …) and software will randomly generate two different groups as a printable document file.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Acute Mountain Sickness.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: On the day of the ascent, the mountaineers will start their ascent from an altitude of 1900 meters from the first station of the Tochal cable car at 8:00 AM. The subjects of mountaineering conditions travel the distance between stations one and two in about 1 hour, and from station two to station five about 2 hours, and from station five to the Tochal hotel about 3 hours, including 1 hour rest between the way and lunch. They arrive at the hotel at about 3:00 p.m. Subjects will return to the low altitude by cable car at 4:00 p.m on the second day of altitude. Intervention 2: Intervention group 2:  On the day of ascent of the cable car subjects, at 8 o'clock in the morning from the first station of the Tochal cable car, they start their ascent from a height of 1900 meters with the cable car. Moving from station two: 10:15 am, Moving from the station Five: 2:30 p.m and arrival at the Tochal hotel is 3:00 p.m. The subjects of the cable car conditions will not have any sports or mountaineering activities and will only be sitting or walking slowly at the stations. Subjects will return to the low altitude by cable car at 4:00 p.m on the second day of altitude. After the implementation of the first program, in the second program, the two groups are replaced. An interval of at least two months between the two programs is considered to eliminate the effect of the compatibility of the first program.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sahba Ariandoost</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1475753661</zip>
        <telephone>+98 83 3427 7605</telephone>
        <email>sahbaemailbox@yahoo.com</email>
        <affiliation>Razi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sahba Ariandoost</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1475753661</zip>
        <telephone>+98 83 3427 7605</telephone>
        <email>sahbaemailbox@yahoo.com</email>
        <affiliation>Razi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Healthy men 20 to 29 years
Lived for at least 6 months in Tehran
Body mass index 18.5 to 24.9 (kg.m2)
At least two weeks have passed since the second dose of Corona vaccine was given</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>29 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Having any acute or chronic illness
Suffering from psychological or skeletal disorders
smoking
Climbing to altitudes of more than 2500 meters in the two months before the start of the research
Blood donation in the two months before the start of the research
Flight by aircraft in the two months prior to the start of the research
History of high-altitude sports such as mountaineering, skiing and air sports</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>T70.29</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other effects of high altitude</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: On the day of the ascent, the mountaineers will start their ascent from an altitude of 1900 meters from the first station of the Tochal cable car at 8:00 AM. The subjects of mountaineering conditions travel the distance between stations one and two in about 1 hour, and from station two to station five about 2 hours, and from station five to the Tochal hotel about 3 hours, including 1 hour rest between the way and lunch. They arrive at the hotel at about 3:00 p.m. Subjects will return to the low altitude by cable car at 4:00 p.m on the second day of altitude.</i_keyword>
      <i_keyword>Intervention group 2:  On the day of ascent of the cable car subjects, at 8 o'clock in the morning from the first station of the Tochal cable car, they start their ascent from a height of 1900 meters with the cable car. Moving from station two: 10:15 am, Moving from the station Five: 2:30 p.m and arrival at the Tochal hotel is 3:00 p.m. The subjects of the cable car conditions will not have any sports or mountaineering activities and will only be sitting or walking slowly at the stations. Subjects will return to the low altitude by cable car at 4:00 p.m on the second day of altitude. After the implementation of the first program, in the second program, the two groups are replaced. An interval of at least two months between the two programs is considered to eliminate the effect of the compatibility of the first program.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Acute Mountain Sickness. Timepoint: About 2 and 6 hours after arrival at the hotel at high altitude as well as the next morning. Method of measurement: Lake Louise Score.</prim_outcome>
      <prim_outcome>Changes in serum interleukin 6 levels. Timepoint: 4 p.m, day before the ascent, 4 p.m, day of the ascent (one hour after arriving at the hotel at high altitude), 4 p.m, the next day (before returning to low altitude). Method of measurement: Blood sampling.</prim_outcome>
      <prim_outcome>Changes in serum endothelin 1 levels. Timepoint: 4 p.m, day before the ascent, 4 p.m, day of the ascent (one hour after arriving at the hotel at high altitude), 4 p.m, the next day (before returning to low altitude). Method of measurement: Blood sampling.</prim_outcome>
      <prim_outcome>Changes in serum Tumor Necrosis Factor-α levels. Timepoint: 4 p.m, day before the ascent, 4 p.m, day of the ascent (one hour after arriving at the hotel at high altitude), 4 p.m, the next day (before returning to low altitude). Method of measurement: Blood sampling.</prim_outcome>
      <prim_outcome>Changes in serum Heat Shock Protein levels. Timepoint: 4 p.m, day before the ascent, 4 p.m, day of the ascent (one hour after arriving at the hotel at high altitude), 4 p.m, the next day (before returning to low altitude). Method of measurement: Blood sampling.</prim_outcome>
      <prim_outcome>Changes in serum Cortisol levels. Timepoint: 4 p.m, day before the ascent, 4 p.m, day of the ascent (one hour after arriving at the hotel at high altitude), 4 p.m, the next day (before returning to low altitude). Method of measurement: Blood sampling.</prim_outcome>
      <prim_outcome>Changes in arterial blood oxygen saturation levels. Timepoint: 4 p.m, the day before the ascent, at the first station of the cable car before the ascent, as well as at stations two and five, at the hotel at high altitude after a 10-minute rest, one hour after arriving at the hotel, at 4 p.m the next day (before returning to low height). Method of measurement: By pulse oximeter device.</prim_outcome>
      <prim_outcome>Resting heart rate changes. Timepoint: 4 p.m, the day before the ascent, at the first station of the cable car before the ascent, as well as at stations two and five, at the hotel at high altitude  after a 10-minute rest, one hour after arriving at the hotel, at 4 p.m the next day (before returning to low height). Method of measurement: Pulse meter.</prim_outcome>
      <prim_outcome>Resting blood pressure changes. Timepoint: 4 p.m, day before the ascent, 4 p.m, day of the ascent (one hour after arriving at the hotel at high altitude), 4 p.m, the next day (before returning to low altitude). Method of measurement: sphygomanometer.</prim_outcome>
      <prim_outcome>Anxiety levels. Timepoint: The day before the ascent at 4:00 p.m, the day of the ascent about 2 and 6 hours after entering the hotel at high altitude and also the next morning before returning to low altitude. Method of measurement: Anxiety Disorders Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Razi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-10</approval_date>
        <contact_name>Ethics committee of Razi University</contact_name>
        <contact_address>Razi University, University Ave, Taq-e Bostan, Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
